PiVOT’s Role In A Multi-Country Phase III GI Trial
Executive Summary A European pharmaceutical sponsor initiated a multi-country phase 3 confirmatory trial to evaluate the efficacy and safety of a once-daily gastrointestinal drug. Its primary contract research organization (CRO) for Southeast Asia and Eastern Europe selected PiVOT to manage operations in the Philippines because of its regulatory expertise, strong site relationships, and a record […]